2-氯硫代苯甲酰胺 | 15717-17-6

• 物质功能分类: 化学试剂 - 有机试剂 - 酰胺
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氯硫代苯甲酰胺
• 中文别名: 2-氯硫代苯胺；邻氯苯硫酰胺
• 英文名称: 2-chlorothiobenzamide
• 英文别名: 2-chlorobenzothioamide；o-chlorothiobenzamide；o-Chlor-thiobenzamid；2-chlorobenzenecarbothioamide
• CAS: 15717-17-6
• 化学式: C₇H₆ClNS
• 分子量: 171.65
• InChiKey: FLQYOORLPNYQEV-UHFFFAOYSA-N

物化性质

• 熔点：
  62-65 °C
• 沸点：
  285.0±42.0 °C(Predicted)
• 密度：
  1.341±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  在常温常压下稳定，避免与氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  58.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险等级：
  6.1
• 危险品标志：
  Xn
• 安全说明：
  S26,S36/37,S37/39
• 危险类别码：
  R22,R36,R43
• 危险品运输编号：
  UN2811
• 海关编码：
  2930909090
• 包装等级：
  III
• 危险类别：
  6.1
• 储存条件：
  常温下应密闭避光，存于通风干燥处。

SDS

Name:	2-Chlorothiobenzamide 98% Material Safety Data Sheet
Synonym:	None Known
CAS:	15717-17-6

Section 1 - Chemical Product MSDS Name:2-Chlorothiobenzamide 98% Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
15717-17-6	2-Chlorothiobenzamide	98%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Keep refrigerated. (Store below 4C/39F.) Store in a tightly closed container. Store in a dry area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 15717-17-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 68 - 70 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H6ClNS
Molecular Weight: 171.65

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 15717-17-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Chlorothiobenzamide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/22 Harmful by inhalation and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 15717-17-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 15717-17-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 15717-17-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氯硫代苯甲酰胺 在 一水合肼 作用下， 以 乙醇 为溶剂， 生成 2-(2-chlorophenyl)-1,3-thiazole-4-carbohydrazide
  参考文献：
  名称：

  新恶二唑和噻唑类似物的合成，晶体结构，抗HIV和抗增殖活性

  摘要：

  合成了一系列2-金刚烷基-5-芳基噻唑基-1,3,4-恶二唑7a – x以及噻唑13和14。化合物7a中-升，13，和14在体外用的鉴定新的铅在MT-4细胞的化合物对人免疫缺陷病毒1型和人免疫缺陷病毒2型活性的活性的目的进行了测试。还测试了标题化合物对革兰氏阳性和革兰氏阴性细菌（金黄色葡萄球菌，沙门氏菌），各种分枝杆菌菌株（Fort分支杆菌和耻垢分枝杆菌（Mycobacterium smegmatis），酵母（白色念珠菌）和霉菌（Aspergillus fumigatus）。除了化合物13和14表现出抗人免疫缺陷病毒1活性（EC 50值为1.79和2.39μM，选择性指数分别为18和4）外，所有化合物均未显示出抗病毒或抗微生物活性。另一方面，化合物7a和7j对人CD4 +淋巴细胞（MT-4）显示出明显的细胞毒性。因此，评估了7a和7j对两种表现出IC的实体肿瘤衍生细胞系的抗增殖活性针对Hep-G2细胞系的50个值分别为8

  DOI：

  10.1007/s00044-016-1669-9
• 作为产物：
  描述：

  在 水 作用下， 生成 2-氯硫代苯甲酰胺
  参考文献：
  名称：

  在水性介质中无金属、一锅法将醛氧化转化为伯硫代酰胺

  摘要：

  摘要 多种醛与氨水、分子碘和 O,O-二乙基二硫代磷酸的一锅串联反应容易得到相应的伯硫代酰胺。这是一种廉价、实用且无金属的方法，可以在水性介质中从醛中获取各种硫代酰胺。简单地通过过滤然后用硫代硫酸钠水溶液和水连续洗涤来获得纯产物。[本文提供补充材料。访问出版商的 Synthetic Communications® 在线版，获取以下免费补充资源：完整的实验和光谱细节。] 图形摘要

  DOI：

  10.1080/00397911.2013.808350
• 作为试剂：
  描述：

  1-(4-fluorophenyl)-2-(4-methylthiophenyl)-2-bromoethanone 以 2-氯硫代苯甲酰胺 、 乙腈 为溶剂， 以50%的产率得到2-(2-chlorophenyl)-4-(4-fluorophenyl)-5-(4-methylthiophenyl)thiazole
  参考文献：
  名称：

  Substituted thiazoles for the treatment of inflammation

  摘要：

  描述了一类取代噻唑基化合物，用于治疗炎症性疾病。这些化合物由公式II定义，其中R.sup.1从氢化物、烷基、卤代烷基、氰基烷基、烷基胺基、芳基烷基、芳基胺基、杂环磺酰基烷基、杂环磺酰基卤代烷基、芳基胺基、芳氧基烷基、烷氧羰基、芳基（在可取代位置上可用一个或多个卤素和烷氧基选择的基团）和杂环（在可取代位置上可用一个或多个卤素和烷基选择的基团）中选择；其中R.sup.4从烷基和氨基中选择；其中R.sup.5从芳基和杂环中选择；其中R.sup.5在可取代位置上可用一个或多个卤素、烷基和烷氧基选择的基团进行取代；只要R.sup.5不是苯基在位置4时，当R.sup.1是α,α-双（三氟甲基）甲醇且R.sup.4是甲基；或其药用可接受盐。

  公开号：

  US05668161A1

文献信息

• Polymer-Supported Diaryl Selenoxide and Telluroxide as Mild and Selective Oxidizing Agents
  作者：Nan Xing Hu、Yoshio Aso、Tetsuo Otsubo、Fumio Ogura

  DOI：10.1246/bcsj.59.879

  日期：1986.3

  Polystyrene-bound diaryl selenoxide and telluroxide have been prepared, which behaved as mild oxidizing agents for thiols to disulfides, phosphines to phosphine oxides, hydroquinone and catechol to p- and o-benzoquinones, and thioketones to oxo compounds. The telluroxide completed these reactions in shorter periods or under milder conditions than the selenoxide. In addition, they effected novel solvent-dependent

  已经制备了聚苯乙烯结合的二芳基硒氧化物和碲氧化物，它们作为硫醇到二硫化物、膦到氧化膦、对苯二酚和邻苯二酚到对和邻苯醌以及硫酮到氧代化合物的温和氧化剂。碲氧化物在比硒氧化物更短的时间内或在更温和的条件下完成这些反应。此外，他们还影响了硫代酰胺与 1,2,4-噻二唑或腈的新型溶剂依赖性反应，包括硫脲。在非酸性溶剂中，脱硫生成腈优先于氧化二聚生成 1,2,4-噻二唑，但酸性溶剂（如乙酸）促进了后者的反应。
• Single-Step Microwave-Mediated Synthesis of Oxazoles and Thiazoles from 3-Oxetanone: A Synthetic and Computational Study
  作者：David Orr、Alexandra Tolfrey、Jonathan M. Percy、Joanna Frieman、Zoë A. Harrison、Matthew Campbell-Crawford、Vipulkumar K. Patel

  DOI：10.1002/chem.201301011

  日期：2013.7.15

  The direct microwave‐mediated condensation between 3‐oxetanone and primary amides and thioamides has delivered moderate to good yields of (hydroxymethyl)oxazoles and (hydroxymethyl)thiazoles. The reactions use a sustainable solvent and only require short reaction times. These are highly competitive methods for the construction of two classes of valuable heteroarenes, which bear a useful locus for further

  3-氧杂环丁酮与伯酰胺和硫代酰胺之间的直接微波介导缩合反应产生了中等到良好的（羟甲基）恶唑和（羟甲基）噻唑收率。反应使用可持续的溶剂，只需要很短的反应时间。这些是构建两类有价值的杂芳烃的高度竞争性方法，它们具有进一步阐明的有用位置。电子结构计算表明，事件的顺序涉及sp 3处硫属元素原子的攻击碳和烷基-氧裂解。清楚地表明了酸催化的关键作用，并证明了酸强度的重要性。计算的势垒也与所观察到的硫酰胺和酰胺反应性顺序完全一致。自发的开环涉及适度的CO裂解，减缓了应力释放的程度。在酸催化的途径上，CO的裂解仍然不太广泛，但是通过羧酸催化剂，质子转移到核反应堆中的进展非常快，而基本上是用甲磺酸完成的。
• Solvent-Free Synthesis of 3,5-di(Hetero)Aryl-1,2,4-Thiadiazoles by Grinding of Thioamides under Oxidative Conditions
  作者：Yali Xu、Jiuxi Chen、Wenxia Gao、Huile Jin、Jinchang Ding、Huayue Wu

  DOI：10.3184/030823410x12677120188989

  日期：2010.3

  An efficient and facile synthesis of 3,5-di(hetero)aryl-1,2,4-thiadiazoles by oxidative dimerisation of thioamides by grinding with NBS under solvent-free conditions at room temperature has been developed. The efficiency of this reaction was demonstrated by the compatibility with trifluoromethyl, methyl, methoxy, chloro, pyridyl and thienyl groups. This method has notable advantages in terms of short reaction times, high yields and is a more practical alternative to the existing methods to access these compounds.

  在室温无溶剂条件下，通过使用 NBS 研磨硫代酰胺氧化二聚物，开发出了一种高效、简便的 3,5- 二（杂）芳基-1,2,4-噻二唑合成方法。该反应与三氟甲基、甲基、甲氧基、氯基、吡啶基和噻吩基的相容性证明了其效率。这种方法具有反应时间短、产率高的显著优势，是获取这些化合物的现有方法之外的一种更实用的替代方法。
• Design, synthesis and Structure–activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes
  作者：Zheng Li、Qianqian Qiu、Xue Xu、Xuekun Wang、Lei Jiao、Xin Su、Miaobo Pan、Wenlong Huang、Hai Qian

  DOI：10.1016/j.ejmech.2016.02.040

  日期：2016.5

  The free fatty acid receptor 1 (FFA1/GPR40) has attracted interest as a novel target for the treatment of type 2 diabetes. Several series of FFA1 agonists including TAK-875, the most advanced compound terminated in phase III studies due to concerns about liver toxicity, have been hampered by relatively high molecular weight and lipophilicity. Aiming to develop potent FFA1 agonists with low risk of

  游离脂肪酸受体1（FFA1 / GPR40）作为治疗2型糖尿病的新靶标已引起人们的关注。相对较高的分子量和亲脂性阻碍了包括FAK1激动剂在内的数个系列的FFA1激动剂（由于对肝毒性的担忧而在III期研究中终止的最先进的化合物）。为了通过降低亲脂性来开发具有低肝毒性风险的有效FFA1激动剂，TAK-875的中间苯基被11个极性五元杂芳族化合物所取代。随后，对SAR的系统探索和分子建模的应用导致了化合物44的鉴定，它是一种出色的FFA1激动剂，在正常和2型糖尿病小鼠中均具有强大的降血糖作用，即使在两倍摩尔的TAK-875剂量下也具有低血糖风险和肝毒性。同时，指出了两个重要发现。首先，我们的噻唑系列中的甲基占据了一个小的疏水亚口袋，与TAK-875没有相互作用。此外，激动活性显示与噻唑核心和末端苯环之间的二面角具有良好的相关性。这些结果促进了对配体结合口袋的了解，并可能有助于设计更有希望的FFA1激动剂。
• Design, synthesis and fungicidal activity evaluation of novel pyrimidinamine derivatives containing phenyl-thiazole/oxazole moiety
  作者：Zhongzhong Yan、Aiping Liu、Yingcan Ou、Jianming Li、Haibo Yi、Ning Zhang、Minhua Liu、Lu Huang、Jianwei Ren、Weidong Liu、Aixi Hu

  DOI：10.1016/j.bmc.2019.05.029

  日期：2019.8

  Diflumetorim is a member of pyrimidinamine fungicides that possess excellent antifungal activities. Nevertheless, as reported that the activity of diflumetorim to corn rust (Puccinia sorghi) was not ideal (EC50 = 53.26 mg/L). Herein, a series of novel pyrimidinamine derivatives containing phenyl-thiazole/oxazole moiety were designed based on our previous study and the structural characteristics of

  地氟美林是嘧啶胺杀菌剂的成员，具有优异的抗真菌活性。然而，据报道，双氟甲蝶呤对玉米锈病（高粱）的活性并不理想（EC50 = 53.26 mg / L）。在此，根据我们先前的研究和双氟甲草胺的结构特征，设计合成了一系列含有苯基-噻唑/恶唑部分的新型嘧啶胺衍生物，并对其进行了生物测定并进行了生物测定，以发现具有优异抗真菌活性的新型杀菌剂。在这些化合物中，T18具有最佳的杀真菌活性，分别对高粱P.orghi和E. graminis的EC50值为0.93 mg / L和1.24 mg / L，具有明显优于商业杀真菌剂diflumetorim，tebuconazole和flusilazole的防治效果。细胞的细胞毒性结果表明，化合物T18的毒性低于双氟甲蝶呤。此外，DFT计算表明，苯基噻唑/恶唑部分在活性提高中起着不可争辩的作用，这将有助于将来设计和开发更有效的化合物。

表征谱图